Relapsed/Refractory Classical Hodgkin's Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Classical Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma (NCT03114683) | Innovent Biologics (Suzhou) Co. Ltd. | 2017-03-30 |
Track Relapsed/Refractory Classical Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.